• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • Arimidex
    • Crestor
    • Nexium
    • Seroquel
    • Symbicort
    • All Drug Products
  • Diseases & Conditions
    • Acid Reflux (Heart Burn)
    • High Cholesterol
    • Asthma
    • Breast Cancer
    • Bipolar Disorder
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • collapse A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group, 2-part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects
  • collapse A Phase I, Open-Label, Study of the Safety and Tolerability of KU-0059436 in combination with Gemcitabine in the Treatment of Patients with Advanced Pancreatic Cancer
  • collapse An open-label, randomized, 4-treatment, 3-period, crossover interaction study, evaluating the effect of esomeprazole 40 mg, omeprazole 80 mg or lansoprazole 60 mg on the pharmacodynamics and the pharmacokinetics of clopidogrel in healthy volunteers
  • collapse A Prospective, Multicenter, Non-interventional Study to Evaluate Quality of Life in Chinese Postmenopausal HR(+) EBC Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
  • collapse A Phase I, Double-blind, Randomized, Placebo-controlled', Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD5213 After Administration of Multiple Ascending Doses for 10 Days in Healthy Male and Non-fertile Female Volunteers
  • collapse Long-term follow-up of antithrombotic management patterns in Acute Coronary Syndrome patients
  • collapse A Phase I, Open Label, Multicenter Study to Assess the Safety, Tolerability and Pharmacology of AZD2281 in Combination with Liposomal Doxorubicin (Caelyx) in Patients with Advanced Solid Tumors
  • collapse Effectiveness of atypical antipsychotics on anhedonic features in patients with schizophrenia
  • collapse Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
  • collapse Evaluation of the control level (GINA) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low), whether an inhaled corticotherapy is taken or not
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010